Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
EMHJ-Eastern Mediterranean Health Journal. 2015; 21 (11): 783-790
in English | IMEMR | ID: emr-174800

ABSTRACT

Noncommunicable diseases [NCDs] are a growing public health challenge. This study aimed to estimate the prevalence of common risk factors for NCDs among the adult population an urban setting in the eastern province of Nangarhar, Afghanistan. In a randomized, cluster sample survey of households the WHO STEPwise method was modified and used to collect demographic, behavioural and clinical data from 1200 adults [61% females] in Jalalabad in 2013. Blood samples were collected for biochemical testing. The prevalence of overweight/obesity, diabetes and hypertension were 57.4%, 11.4% and 24.4% respectively. Among respondents, 8.0% reported being current cigarette smokers and 13.7% used mouth snuff; 69.8% and 19.6% had < 3 servings of fruits and of vegetables respectively in a week; and 33.5% and 57.8% reported vigorous and moderate physical activity respectively. Tailored interventions on risk factors of NCDs are needed in urban areas in Afghanistan


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Prevalence , Epidemiology , Risk Factors , Surveys and Questionnaires
2.
EMHJ-Eastern Mediterranean Health Journal. 2012; 18 (9): 946-950
in English | IMEMR | ID: emr-158985

ABSTRACT

At the end of March 2010 an A/H1N1 vaccination campaign was conducted in Afghanistan using donated vaccines. However, no surveillance system for detection of adverse events following immunization was in place. We report a cross-sectional, descriptive survey in 4 provinces of Afghanistan to assess the rate of adverse events among health care staff immunized with A/H1N1 monovalent vaccine 4 weeks after vaccination. Using random sampling proportionate to size, 350 staff [mean age 36 years, range 16-65 years] were surveyed using a questionnaire. The highest self-reported rates of adverse events were pain at the injection site [53%], fever in the first 3 days after immunization [40%], body pain [39%], tiredness [33%], swelling at the injection site [29%] and redness at the injection site [28%]. More females than males suffered adverse reactions and the rates varied across different provinces, ranging from 79% in Balkh to 23% in Kabul


Subject(s)
Humans , Male , Female , Influenza A Virus, H1N1 Subtype/immunology , Health Personnel , Cross-Sectional Studies , Surveys and Questionnaires , Pain , Fever , Immunization
SELECTION OF CITATIONS
SEARCH DETAIL